Aurobindo Pharma Limited
AUROPHARMA
Rangering i aksjer
#2072
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aksjekurs
$17.34
Markedsverdi
$9.98B
Endring (1 dag)
-3.08%
Endring (1 år)
38.71%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)
Kategori
Healthcare
P/S-forhold for Aurobindo Pharma Limited (AUROPHARMA)
P/S-forhold per October 2026 TTM: 2.77
Ifølge Aurobindo Pharma Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 2.77. Ved slutten av 2024 hadde selskapet et P/S-forhold på 2.25.
P/S-historikk for Aurobindo Pharma Limited fra 2004 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.77 | 33.31% |
| 2025 | 2.08 | -7.36% |
| 2024 | 2.25 | 82.40% |
| 2023 | 1.23 | -26.44% |
| 2022 | 1.68 | -20.27% |
| 2021 | 2.10 | 97.49% |
| 2020 | 1.06 | -55.13% |
| 2019 | 2.37 | 10.73% |
| 2018 | 2.14 | -20.47% |
| 2017 | 2.69 | -15.48% |
| 2016 | 3.19 | 7.66% |
| 2015 | 2.96 | 59.79% |
| 2014 | 1.85 | 142.25% |
| 2013 | 0.77 | 0.21% |
| 2012 | 0.76 | -40.71% |
| 2011 | 1.29 | -11.40% |
| 2010 | 1.45 | 342.21% |
| 2009 | 0.33 | -48.77% |
| 2008 | 0.64 | -62.35% |
| 2007 | 1.70 | -24.28% |
| 2006 | 2.25 | 103.16% |
| 2005 | 1.11 | -7.07% |
| 2004 | 1.19 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 154.53% |
IN
|
